Reply.

Matthew B Schlenker; Husayn Gulamhusein; Ina Conrad-Hengerer; Alix Somers; Markus Lenzhofer; Ingeborg Stalmans; Herbert Reitsamer; Fritz H Hengerer; Iqbal Ike K Ahmed

doi:10.1016/j.ophtha.2017.09.012

Reply.

Matthew B Schlenker, Husayn Gulamhusein, Ina Conrad-Hengerer, Alix Somers, Markus Lenzhofer (Co-author), Ingeborg Stalmans, Herbert Reitsamer (Co-author), Fritz H Hengerer, Iqbal Ike K Ahmed

Department of Ophthalmology

Research output: Contribution to journal › Author reply › peer-review

1 Citation (Web of Science)

Original language	English
Pages (from-to)	e17-e18
Journal	OPHTHALMOLOGY
Volume	125
Issue number	2
DOIs	https://doi.org/10.1016/j.ophtha.2017.09.012
Publication status	Published - 2018

Keywords

MITOMYCIN-C
COMBINED PHACOEMULSIFICATION
SUBCONJUNCTIVAL BEVACIZUMAB
CONTROLLED-TRIAL
GLAUCOMA
OUTCOMES

Access to Document

10.1016/j.ophtha.2017.09.012

Cite this

Schlenker, M. B., Gulamhusein, H., Conrad-Hengerer, I., Somers, A., Lenzhofer, M., Stalmans, I., Reitsamer, H., Hengerer, F. H., & Ahmed, I. I. K. (2018). Reply. OPHTHALMOLOGY , 125(2), e17-e18. https://doi.org/10.1016/j.ophtha.2017.09.012

Schlenker, Matthew B ; Gulamhusein, Husayn ; Conrad-Hengerer, Ina et al. / Reply. In: OPHTHALMOLOGY 2018 ; Vol. 125, No. 2. pp. e17-e18.

@article{b0d7b675e647499dbcd4584e736cbc64,

title = "Reply.",

keywords = "MITOMYCIN-C, COMBINED PHACOEMULSIFICATION, SUBCONJUNCTIVAL BEVACIZUMAB, CONTROLLED-TRIAL, GLAUCOMA, OUTCOMES",

author = "Schlenker, {Matthew B} and Husayn Gulamhusein and Ina Conrad-Hengerer and Alix Somers and Markus Lenzhofer and Ingeborg Stalmans and Herbert Reitsamer and Hengerer, {Fritz H} and Ahmed, {Iqbal Ike K}",

note = "Lenzhofer, M; Reitsamer; H: Department of Ophthalmology and Optometry, Paracelsus Medical University Salzburg, Salzburg, Austria",

year = "2018",

doi = "10.1016/j.ophtha.2017.09.012",

language = "English",

volume = "125",

pages = "e17--e18",

journal = "OPHTHALMOLOGY ",

issn = "0161-6420",

number = "2",

}

Schlenker, MB, Gulamhusein, H, Conrad-Hengerer, I, Somers, A, Lenzhofer, M, Stalmans, I, Reitsamer, H, Hengerer, FH & Ahmed, IIK 2018, 'Reply.', OPHTHALMOLOGY , vol. 125, no. 2, pp. e17-e18. https://doi.org/10.1016/j.ophtha.2017.09.012

Reply. / Schlenker, Matthew B; Gulamhusein, Husayn; Conrad-Hengerer, Ina et al.
In: OPHTHALMOLOGY , Vol. 125, No. 2, 2018, p. e17-e18.

Research output: Contribution to journal › Author reply › peer-review

TY - JOUR

T1 - Reply.

AU - Schlenker, Matthew B

AU - Gulamhusein, Husayn

AU - Conrad-Hengerer, Ina

AU - Somers, Alix

AU - Lenzhofer, Markus

AU - Stalmans, Ingeborg

AU - Reitsamer, Herbert

AU - Hengerer, Fritz H

AU - Ahmed, Iqbal Ike K

N1 - Lenzhofer, M; Reitsamer; H: Department of Ophthalmology and Optometry, Paracelsus Medical University Salzburg, Salzburg, Austria

PY - 2018

Y1 - 2018

KW - MITOMYCIN-C

KW - COMBINED PHACOEMULSIFICATION

KW - SUBCONJUNCTIVAL BEVACIZUMAB

KW - CONTROLLED-TRIAL

KW - GLAUCOMA

KW - OUTCOMES

U2 - 10.1016/j.ophtha.2017.09.012

DO - 10.1016/j.ophtha.2017.09.012

M3 - Author reply

C2 - 29389416

SN - 0161-6420

VL - 125

SP - e17-e18

JO - OPHTHALMOLOGY

JF - OPHTHALMOLOGY

IS - 2

ER -

Schlenker MB, Gulamhusein H, Conrad-Hengerer I, Somers A, Lenzhofer M, Stalmans I et al. Reply. OPHTHALMOLOGY . 2018;125(2):e17-e18. doi: 10.1016/j.ophtha.2017.09.012